Suppr超能文献

移植肝后心血管事件的预测因素:移植前血清肌钙蛋白水平的作用。

Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.

机构信息

Mayo Clinic Transplant Center, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

出版信息

Liver Transpl. 2011 Jan;17(1):23-31. doi: 10.1002/lt.22140.

Abstract

Cardiovascular complications are major causes of morbidity and mortality after liver transplantation. Identifying candidates at highest risk of postoperative complications is a cornerstone of optimizing outcomes and utility. Using traditional cardiac risk factors in addition to C-reactive protein (CRP) levels, troponin levels, and echocardiographic parameters before transplantation, we sought to define cardiac risk so that we could predict cardiovascular events after transplantation. From December 1998 to December 2001, 230 adult patients who underwent liver transplantation with a median follow-up of 8.2 years were studied. The risk factors for cardiac disease were as follows: male gender with a mean age of approximately 50 years (57%), smoking history (60%), diabetes (23%), hypertension (19%), elevated troponin (25%), elevated CRP (25%), and preexisting cardiac disease (16%). Fifty-nine cardiac events occurred over 8.2 years. Risk factors (univariate analysis) for first cardiac events included age in decades [hazard ratio (HR) = 1.31, P = 0.047], diabetes (HR = 2.20, P = 0.004), prior cardiovascular disease (HR = 4.77, P < 0.0001), a troponin I level > 0.07 ng/mL (HR = 2.00, P = 0.023), left ventricular hypertrophy (HR = 2.06, P = 0.047), stress wall abnormalities (HR = 2.25, P = 0.018), and ischemia on stress imaging (HR = 2.89, P = 0.015). Multivariate analysis confirmed age, diabetes, a troponin I level > 0.07, and prior cardiac disease as independent risk factors for posttransplant cardiac events. In conclusion, pretransplant elevated troponin levels, diabetes, and a history of cardiovascular disease, alone or in combination, are strongly associated with the occurrence of posttransplant cardiovascular events.

摘要

心血管并发症是肝移植后发病率和死亡率的主要原因。确定术后并发症风险最高的患者是优化结果和实用性的基石。我们在移植前使用传统的心脏危险因素,外加 C 反应蛋白 (CRP) 水平、肌钙蛋白水平和超声心动图参数,旨在定义心脏风险,以便预测移植后的心血管事件。

从 1998 年 12 月至 2001 年 12 月,我们研究了 230 名接受肝移植的成年患者,中位随访时间为 8.2 年。心脏疾病的危险因素如下:男性,平均年龄约 50 岁(57%),吸烟史(60%),糖尿病(23%),高血压(19%),肌钙蛋白升高(25%),CRP 升高(25%),以及存在心脏疾病(16%)。在 8.2 年内发生了 59 次心脏事件。首次心脏事件的危险因素(单因素分析)包括年龄(每十年 HR = 1.31,P = 0.047)、糖尿病(HR = 2.20,P = 0.004)、先前的心血管疾病(HR = 4.77,P < 0.0001)、肌钙蛋白 I 水平> 0.07ng/mL(HR = 2.00,P = 0.023)、左心室肥厚(HR = 2.06,P = 0.047)、应激性壁异常(HR = 2.25,P = 0.018)和应激成像时的缺血(HR = 2.89,P = 0.015)。多因素分析证实年龄、糖尿病、肌钙蛋白 I 水平> 0.07ng/mL 和先前的心脏疾病是移植后心脏事件的独立危险因素。

总之,移植前肌钙蛋白水平升高、糖尿病和心血管疾病史,单独或联合存在,与移植后心血管事件的发生密切相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验